PTSM: Pharmaceutical Technology Sourcing and Management, Feb 5, 2014 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Feb 5, 2014
Outsourcing Outlook
Evolving R&D Model Pressures Contract Services Market
By Jim Miller
The R&D model is in transition and creating new demands on contract services providers.
Contract Manufacturing
The State of Drug Manufacturing in India
By Siegfried Schmitt
Some recent high-profile cases of quality issues at Indian manufacturers have given reason to examine manufacturers more closely.
Will CMOs Provide Sufficient Capacity for Growing Biologics Demand
By Cynthia Challener, PhD
With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.
CSR and Sustainability Forum
AstraZeneca, BMS Provide Grant for Diabetes Research Initiative
By Melanie Sena
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides a $5 million grant to the American Diabetes Association.
Catalent Applied Drug Delivery Institute Partners with AAPS on 3rd Annual Global Academic Competition
Competition seeks to encourage academic research and accelerate drug delivery applications.
Supply Chain
BASF Receives EXCiPACT Certification
By Melanie Sena
BASF receives EXCiPACT Certification for the group of polyvinylpyrrolidone polymers, produced in Germany.
VWR International Locations Join Avantor Performance Materials Distributor Program
By Melanie Sena
Avantor Performance Materials adds VWR International locations to its certified excipient distributor program.
Contract Services
SGS Announces Formulation and Stability Testing Services, New Labs
SGS to offer program-based stability testing services for biopharmaceuticals from Wokingham, UK facility.
Regis Technologies Reports Successful FDA Audit
By Melanie Sena
Regis Technologies passes a recent FDA audit with no Form 483 observations.
PharmaCell to Purchase Cell Therapy Production Facility from TiGenix
By Melanie Sena
PharmaCell enters an agreement purchase TiGenix therapy production facility.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here